Soc. Generale Knock-Out GSK/ DE000SD8PDH4 /
07/05/2024 21:47:26 | Var.+0.290 | Denaro21:59:09 | Lettera21:59:09 | Sottostante | Prezzo di esercizio | Expiration date | Tipo di opzione |
---|---|---|---|---|---|---|---|
10.830EUR | +2.75% | 10.820 Quantità in denaro: 300 |
11.010 Quantità in lettera: 300 |
Gsk PLC ORD 31 1/4P | 8.2657 GBP | 31/12/2078 | Call |
GlobeNewswire
22:02
AXTI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that AXT Inc Investors with Substan...
GlobeNewswire
22:02
TPI Composites Partners with University of Maine and Oak Ridge National Laboratory to Leverage One o...
GlobeNewswire
22:02
Inspire Medical Systems, Inc. Announces First Quarter 2024 Financial Results and Updates 2024 Outloo...
GlobeNewswire
22:01
Kiniksa Pharmaceuticals to Present at Bank of America Securities 2024 Health Care Conference
GlobeNewswire
22:01
Xenon Pharmaceuticals to Present at the 2024 RBC Capital Markets Global Healthcare Conference
GlobeNewswire
22:01
Conifer Holdings Schedules First Quarter 2024 Earnings Conference Call/Webcast for May 15, 2024
GlobeNewswire
22:01
Denali Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights
GlobeNewswire
22:01
Grocery Outlet Holding Corp. Announces First Quarter Fiscal 2024 Financial Results
GlobeNewswire
22:01
Aclaris Therapeutics Reports First Quarter 2024 Financial Results and Provides a Corporate Update
GlobeNewswire
22:01
TRACON to Report First Quarter 2024 Financial Results and Provide Corporate Update on May 14, 2024
GlobeNewswire
22:00
Pacira BioSciences Reports First Quarter 2024 Financial Results and Announces $150 Million Share Rep...
GlobeNewswire
22:00
Inception Growth Acquisition Limited Announces Listing Transfer to the Nasdaq Capital Market